- Oslo Cancer Cluster - https://oslocancercluster.no -

Lifandis, Smartfish and BerGenBio got funding from BIA

The Norwegian Research Council granted BerGenBio, Lifandis and Smartfish –¬† all Oslo Cancer Cluster member companies – funding through the Programme for User-Driven Research Based Innovation (BIA).

In total, the Research Council will grant a record amount of over 600 MNOK to 65 Norwegian companies, of which 9 are biotech companies.

BerGenBio, Lifandis and Smartfish will receive around 10 million NOK each over 4 years, depending on the outcome of the contract negotiations between the council and the companies. Funding from the BIA programme is a quality stamp since the companies compete in “open class” where all sectors are represented. The funding may also trigger interest¬† from private investors. BerGenBio also received funding from BIA one year ago.

On the Research Council`s website you may more information and a list of all the companies [1] that received funding now (in Norwegian).

October 14th 2015 is next application deadline  for funding from the BIA-programme [2].